Skip to main content

Ubrelvy News

Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms

WEDNESDAY, May 14, 2025 – Migraines don’t just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What’s more, those n...

Ubrogepant During Prodromal Phase of Migraine Eases Symptoms

TUESDAY, May 13, 2025 – Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature Medicine. Peter J. Goadsby,...

FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine

DUBLIN, Dec. 23, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy (ubrogepant) for...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Migraine

Ubrelvy patient information at Drugs.com